A biotech company needed to rapidly achieve first patient in (FPI) for a novel glioblastoma therapy trial. With December holiday closures and a tight first-quarter FPI goal, we expedited all trial startup activities, from site initiation and clinical database build to imaging solution procurement.
Read our case study to learn about our strategic steps for accelerating enrollment and achieving the FPI milestone in under two months.
